Clinical evaluation of an Ayurvedic therapyâ€“ Sutashekhara Rasa and Brihat Jeevakadya Taila Nasya in the management of Ardhavabhedaka (Migraine) by Mata, Shweta et al.
Published online in http://ijam. co. in 
  ISSN: 0976-5921 
International Journal of Ayurvedic Medicine, 2015, 6 (2), 150-159 
 
150 
Clinical evaluation of an Ayurvedic therapy– SutashekharaRasaand Brihat 
Jeevakadya Taila Nasya in the management of Ardhavabhedaka (Migraine) 
 
Research Article 
 
Shweta Mata1*, Vaghela DB2, Dhiman KS3, Parth Dave4 
 
1. PG scholar, 2. Assistant Professor, 3. Director & Head of the department, 4. Ph.D. Scholar, 
Dept. of Shalakya Tantra,I. P. G. T. & R. A.,G. A. U., Jamnagar.  
 
Abstract 
 
Ardhavabhedaka-hemicranial headache is a psychosomatic disorder: later replaced by 
migraine a Greek word "half of the head" because the pain of migraine often occurs on one 
side(classical Migraine) may affect the entire head. The term "migraine" refers to a syndrome 
of vascular pathology of the cranial blood vessels and is one of the commonest headache 
encountered in clinical practise. The survey results suggested that both patients and physicians 
believe migraine treatment is elusive and that patients are becoming increasingly frustrated and 
dissatisfied with treatment outcomes. Clinically, it is a Rakta/Pitta dominant 
disease;andAcharya Charaka opined that the vitiated Doshas after reaching Shirah vitiates 
Rakta (Rasavaha and Raktavaha Srotas) there to produce Shiro Roga (headache). Its diagnosis 
is based on mainly clinical history. For the present study, it was planned to compare the result 
between Brihat Jeevakadhya Taila Nasyaand Sutashekhara Rasa orally (Pitashamaka, 
Raktashodhaka, Deepana etc.) in Treatment Trial group and Flunarizine in Control group. The 
overall effect of therapy showed that in Trial group 80. 00% patients had marked improvement, 
followed by moderate improvement in 13. 33% and complete improvement in 6. 67%. In 
control group marked and moderate improvement was seen in 60. 00% and 33. 33% 
respectively; and 6. 67% had mild improvement. No any adverse drug reaction was found 
during whole study. Total 30 patients were registered and from the results and observation 
which were received from this study it can be concluded that Trial group is showing better 
results in Ardhavabhedaka.  
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Introduction: 
 Headache in general is one of the 
commonest complain of the people seeking 
medical help. Of all the disorders that present 
to the clinician with headache, migraine is the 
commonest and also the most burdensome. 
Migraine is one of the most disabling of 
neurological disorders. The World Health 
Organization (WHO) has identified migraine 
among the world’s top 20 leading causes of 
disability (1). More than 2/3rd of Migraine 
sufferers either have never consulted a doctor 
or have stopped doing so (2). Moreover 
routine use of these drugs leads to GI tract 
disturbance. In contrast to that Ayurveda has 
a variety of natural medication in the 
treatment of various varieties of Shirah-
Shoola, and these recipes are free from above 
mentioned GIT complications and rather safe 
in use. Clinically, it is a Pitta dominant 
disease; and Acharya Charaka opined that 
the vitiated Doshas after reaching Shirah 
*Corresponding Author: 
Shweta Mata 
PG Scholar,  
Department of Shalakya Tantra 
I. P. G. T. & R. A., G. A. U.,  
Jamnagar  
E-mail: shwetamatadr@gmail.com 
Published online in http://ijam. co. in 
  ISSN: 0976-5921 
Shweta Mata et. al., Ayurvedic Management of Ardhavabhedaka (Migraine) 
 
151 
vitiates Rakta (Rasavaha and Raktavaha 
Srotas) there to produce Shiro Roga 
(headache)(3). Thus, Rakta is the main 
Dushya in Ardhavabhedaka. Its diagnosis is 
based on mainly clinical history. The study 
was conducted in I. P. G. T. & R. A., hospital. 
In this study, 30 patients were selected and 
Sutashekhara Rasa orally and Brihat 
Jeevakadhya Taila Nasya were given for its 
Pittashamaka, Raktashodhaka, Deepana etc. 
properties for 45days. For the present study, 
an attempt has been made to treat “the 
disease” by identifying the risk factors for the 
disease and preventing the recurrence of the 
disease in the individual by explaining 
Pathya Apathya.  
For the present study it was planned 
to evaluate the efficacy of Brihat Jeevakadya 
Taila Nasya and SutashekharaRasain the 
management of Ardhavabhedaka.  
 
Aims and objectives: 
The present study was based on 
following aims and objects: 
1. To study and understand the 
etiopathogenesis of Ardhavabhedaka 
(Migraine) in Ayurvedicclassical 
literature.  
2. To evaluate the role of adopted line of 
treatment/ trail drugs in the management 
of Ardhavabhedaka (Migraine).  
 
Materials and methods: 
The study was approved by 
Institutional Ethics Committee (No. 
PGT/7/A/Ethics/2013-14/1767 dated on 
10/09/2013). Patients were selected from the 
O. P. D. of Dept. of Shalakya –Tantra and 
referred from other dept. of I. P. G. T. & R. 
A., G. A. U. Jamnagar. Patients’ written 
informed consent was taken before starting 
the treatment. Patients were selected using 
‘Simple random sampling method’. The 
study was conducted in 30 subjects.  
 
Diagnostic criteria:  
Criteria for inclusion: Age Control 
groupetween 20 to 60 years and having sign 
and symptom ofArdhavabhedaka (Migraine) 
According to Ayurvedic Classics as well as 
Modern science.  
Criteria for exclusion:  
Patients having any chronic 
debilitating disease with other    neurological 
pathology or having Sinusitis, Hypertension, 
Secondary headache caused by meningitis, 
tumor, encephalitis, cervical spondylitis and 
refractive errors, age Control group below 16 
& above 60 etc. were excluded from the 
study.  
 
Grouping: 
Group A-Trial group  
Group B-Control group 
Intervention: 
Before starting the treatment 
Deepana-Pachana with Sunthi Churna 2gm 
2 times or Chitrakadi Vati 2 Tablet thrice a 
day was given for 3 days followed by Kostha 
Shuddhi (Mridu Virechana) with Triphala 
Churna 6gm at bed time was givenfor 3 days 
in group A patients.  
 
Group A-Trial group: 
(1)Brihat Jeevakadya Taila Nasya(4): 
Nasya was done in the dose of 6 drops 
in each nostril for 2 sittings of seven days 
with the interval of 15 days after each sitting. 
Total duration was one and half month.  
 
(2)Sutashekhara Rasa Vati (5): 
Vatiwas given in the dose of 250mg 
BD with DrakshajalaAnupana for one and 
half month.  
Drakshajala: 25 gm of dried Draksha is 
soaked in 200 ml of water overnight and in 
the next day morning, it is crushed and 
filtered through a clean cloth and that water is 
used as Anupana. (Anubhuta) 
 
Group B- Control group: 
Flunarizine Tab 10mg OD was given for 45 
days.  
Patients were diagnosed on the basis of 
subjective criteria of diseases.  
 
Investigations: 
        Routine hematological and urine 
analysis were carried out before treatment to 
rule out any systemic diseases.  
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Scoring pattern: 
Subjective symptoms  
The improvement in patients was 
assessed on the basis of relief in the signs and 
symptoms of the disease. The details of the 
score adopted for the main signs and 
symptoms in this study are as follows: 
 
❖ Severity of Headache 
0 = No headache.  
1 = Mild headache, patient is aware only if 
he/she pay attention to it.  
2 = Moderate headache, can ignore at times.  
3 = Severe headache, can’t ignore but he/she 
can do his/her usual activities.  
4 = Excruciating headache, can’t do 
anything.  
 
❖ Frequency of Headache: Assessed in 
term of (frequency in days) 
0 = Nil 
1 = ≥ 20 days 
2 = 15 days 
3 = 10 days 
4 = ≤ 5 days 
 
❖ Duration of Headache: (Assessed in term 
of hours/day) 
0 = Nil 
1 = 1-3 hours/day 
2 = 3-6 hours/day 
3 = 6-12 hours/day 
4 = More than 12 hours/day 
 
❖ Nausea: 
0 = Nil 
1 = Occasionally 
2 = Moderate, but does not disturb the 
routine work 
3 = Severe, disturbing routine work 
4 = Severe enough, small amount of fluid 
regurgitating from Mouth 
 
❖ Vomiting: 
0 = Nil 
1 = Only if headache does not subside 
2 = Vomiting 1-2 times 
3 = Vomiting 2-3 times 
4 = Forced to take medicine to stop vomiting 
 
❖ Vertigo: 
0 = Nil 
1 = Feeling of giddiness 
2 = Patient feels as if everything is revolving 
3 = Revolving signs + black outs 
4 = Unconscious 
 
❖ Aura: 
0 = Nil 
1 = Lasts for 5 minutes.  
2 = Lasts for 15 minutes 
3 = Lasts for 30 minutes 
4 = Lasts for 60 minutes 
 
❖ Gradation For Associated Symptoms: 
0 = No symptoms 
1 = Mild (can do his/her work) 
2 = Moderate (forced to stop work) 
3 = Severe (forced to take rest) 
4 = Excruciating (force to take medicine) 
 
Overall assessment: 
The improvement was assessed on 
the basis of subjective symptoms and salivary 
tests (objective parameters).  
Subjective: The assessment was done by 
adopting the following scoring pattern for 
subjective symptoms- 
1. Complete Remission: 100% relief in 
objective and subjective signs and 
symptoms.  
2. Marked improvement: 76 – 99% relief in 
objective and subjective signs and 
symptoms.  
3. Moderate improvement: 51 – 75% relief 
in objective and subjective signs and 
symptoms.  
4. Mild improvement: 26 – 50% relief in 
objective and subjective signs and 
symptoms.  
5. Unchanged: Below 25% relief in 
objective and subjective signs and 
symptoms.  
 
Statistical estimation of results: 
The obtained data were analyzed 
statistically. The values were expressed as 
percentage of relief and Standard Error Mean. 
The data were analyzed by paired ‘t’ test. 
Unpaired ‘t’ test was applied for comparative 
study.  
P > 0. 05 = Insignificant 
P < 0. 05 and 0. 01 = Significant 
P < 0. 001 = Highly significant 
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Observations and Results 
In this clinical trial of 
Ardhavabhedaka, a total number of 30 
patients were registeredand were randomly 
distributed into two groups. 15 patients 
registered in each group. The general 
observations are shown in FIGURE NO. 1 
Observation reveals that, regarding 
the chief complaints 100% patients were 
having Shirah-Shoola (headache), followed 
by Hrillas (nausea) and Chhardi (vomiting) 
93. 33% and 80. 00% respectively, Bhrama 
(vertigo) 46. 67%, and Aura 66. 67%, which 
are identical to the textual Lakshana 
(symptoms) of Ardhavabhedaka and 
migraine.   
Regarding the associated symptoms 
63. 33% patients were having Photophobia, 
66. 67% patients were having Phonophobia, 
30. 00% were having Ocular pain, 33. 33% 
were having Eyelid edema, 26. 67% patients 
had blurring of vision, 23. 33% had 
Lacrimation, 50. 00% patients had Stiffness 
of neck followed by other symptoms, which 
tally with textual Lakshana of 
Ardhavabhedaka and migraine.  
Regarding the Shirah-Shoola, 
Maximum (76. 67%) patients were having 
unilateral headache, that also particularly 
more in frontal and temporal region i. e., 53. 
33% each, nature of pain was Tivra (sharp) in 
96. 67% patients. Regarding the quality of 
headache, maximum patients (86. 67%) were 
having Shankhanistoda, Akshi Nishkashanvat 
Pida (53. 33%), Ghatasambheda (43. 33%) 
followed by others. The intensity of headache 
was excruciating in 60% of patients. 
Maximum patients (53. 33%) were having 
chronicity of >5 years. Maximum patients 
(66. 67%) were having gradual onset of 
headache. The duration >12 hours of 
headache was seen maximum i. e., 40. 00%. 
Regarding frequency, the episode at an 
interval of ≤ 5 days was seen maximum i. e., 
80. 00%. Maximum patients (63. 33%) were 
found to be having continuous nature of 
headache. This shows that majority of the 
patients either have never consulted a doctor 
or have stopped doing so, which suggests the 
chronicity of disease. It was observed that 
patients rely on painkiller without any 
medical advice given by physician, in a hope 
to get rid of the headache quickly. But it was 
not going to stop the pathology. And the 
patients, who were taking anti-migraine 
drugs, were not responding. This results in 
chronic migraines i. e., rebound or 
transformed migraine headache.  
The maximum Nidanas (etiological 
factors) observed in patients were Lavana-
Amla Aahara (66. 67%), Samshana (50. 
00%), Vishamashana (26. 67%), followed by 
Ratrijagarana 26. 67% and Diwaswapa 80. 
00%. This shows faulty lifestyle, which is 
accepted by today’s generation. Intake of 
junk food, taking food at any time, fasting 
habits of females, etc lead to Agnimandhya 
and Tridosha Dushti, which contributes 
chiefly in the pathogenesis of the disease. 
Also tyramine and other amines present in 
today’s junk and sour-spicy food causes 
dilation of the nerves in the brain, resulting in 
a rush of blood. Faulty diet causes 
Constipation (23. 33%) and 
Hyperchlorhydria (70. 00%), which was 
observed by patients at the time of migraine 
headache.  
Similarly Ratrijagarana and 
Diwaswapa aggravate Vata and Kapha 
Dosha respectively. Also disturbed sleep was 
observed in maximum patients i. e., 33. 33%. 
Disturbances such as sleep deprivation, too 
much sleep, poor quality of sleep and 
frequent awakening at night are associated 
with both migraine and tension headaches, 
whereas improved sleep habits helps in 
reducing the frequency of migraine 
headaches. Sleep also has been reported to 
shorten the duration of migraine headaches.  
Environmental factors, like Dhupa 
(86. 67%), Dhuma (23. 33%), Dhuli (20. 
00%) causes the Atiyoga of Indriyas and 
serves as a triggering factor. Female’s 
emotional nature, the responsibilities of the 
family were the cause of mental factors such 
as Chinta (86. 67%), Krodha (70. 00%), 
Bhaya (50. 00%) and Shoka (43. 33).  
Sunlight was observed as maximum 
triggering factor i. e., 83. 33%. Bright lights 
and other high intensity visual stimuli can 
cause headaches in healthy subjects as well as 
patients with migraine headaches, but 
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migraine patients seem to have a lower than 
normal threshold for light-induced pain. 
Sunlight, television and flashing lights all 
have been reported to precipitate migraine 
headaches.  
Emotional (73. 33%) and physical 
stress (40. 00%) also acts as triggering factor. 
This may lead to Dhatukshaya and vitiation 
of Vata Dosha. Awakning/Journey (56. 66%) 
served as triggering factor because it also 
leads to vitiation of VataDosha. Skipping 
breakfast/fasting habbits (40. 00%) served as 
triggering factor because it possibly may 
precipitate migraine headaches by causing 
the release of stress-related hormones and 
lowering blood sugar.  
 
Effect of therapies on signs & symptoms: 
Regarding effect of therapy on Chief 
complaints, both the group showed 
significant results. Statistically highly 
significant (<0. 001) improvement in severity 
(81. 03%), duration (73. 46%) and frequency 
(75. 86%) of headache was obtained in trial 
group, followed by statistically highly 
significant (<0. 001) improvement in severity 
(66. 66%), duration (63. 41%) and frequency 
(61. 11%) of headache in Control group. 
TABLE NO. 1 & 2 
Effect of therapy on other associated 
complaints showed that in trial group 95. 
12% relief in Nausea, 82. 75% in Vomiting, 
100% in Vertigo and 100% in Aura was 
obtained, which was statistically significant. 
While in Control Group, Nausea was relieved 
by 76. 66%, Vomiting by 94. 44%, and 
Vertigo by 63. 63%, which were statistically 
significant. But no significant result in Aura 
(<0. 05) was obtained. This shows that Trial 
group therapy was more effective than 
control group therapy on chief complaints. 
TABLE NO. 3 & 4 
The associated symptoms like 
Blurring of vision, Photophobia, Ocular pain, 
Eyelid oedema, Phonophobia were relieved 
by 96. 55%, 90. 00%, 80. 00%, 90. 91%, 96. 
55 in Treatment Trial groupnd 72. 72%,88. 
23%, 80. 00%, 85. 71% and 89. 47 in Control 
group respectively, which were statistically 
highly significant (<0. 001). The other 
associated symptoms like Hyperchlorhydria 
and Constipation were relieved by 92. 85% 
and 100% in Trial group which were 
statistically highly significant and 35. 29% 
and 60. 00% in Control group respectively, 
which were statistically insignificant. This 
shows that Trial group therapy was more 
effective than control group therapy on 
associated symptoms. TABLE NO. 5 & 6 
 
Total effect of therapy:  
The overall effect of therapy showed 
that in Trial group 80. 00% patients had 
marked improvement, followed by moderate 
improvement in 13. 33% and complete 
improvement in 6. 67%. In control group 
marked and moderate improvement was seen 
in 60. 00% and 33. 33% respectively; and 6. 
67% had mild improvement. Not a single 
case was noted unchanged in any of the 
groups. FIGURE NO. 2 
 
Probable Mode of action: 
In the present study Sutashekhara 
Rasa used for systemic treatment of 
Ardhavabhedaka. SutashekharaRasa is 
mentioned in Yogratnakara for Amlapitta 
rogadhikara. The compound was slightly 
modified to meet the cost factor i. e. Swarna 
Bhasma was replaced by Swarna Makshika 
Bhasma(6). In Ardhavabhedaka, the root 
cause is Agnimandhya. So if Agnimandhya is 
treated, best production of Rasa-Rakta Dhatu 
occurs. We can’t establish that the particular 
drug acts by their Rasa, Guna, Virya, Vipaka 
mentioned in Yoga.  
 
Dominant Rasa Panchaka of Sutashekhara 
Rasa(7) 
Rasa is Katu, Tikta, Madhura, Guna 
is Snigdha, Laghu, Tikshana, Virya is 
Ushna, Vipaka is Katu and Doshgnata is 
Vata-Pitta shamaka.  
KatuRasa and TiktaRasa have 
Deepana – PachanaKarma(8), which causes 
Amapachana and thus provides proper 
metabolism and ultimately balances the Agni. 
Thus these Rasa works at AgniDushti stage in 
the Samprapti of Ardhavabhedaka and pacify 
the KaphaDosha.  
UshnaViryahas Deepana – 
Pachanaproperty, which acts as 
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Agnideepaka. It also softenes and liquefies 
the morbidDoshas which are ultimately 
removed due to VirechakaKarma, 
therebyrelieving constipation.  
SnigdhaGuna, and MadhuraRasa 
having the property Srushtavinamutra, which 
relieves the symptoms of constipation and 
hyperchlorhydria and pacify the VataDosha 
and PittaDosha.  
SnigdhaGuna has KledanaKarma(9) 
which acts as a binding agent and also 
strengthens the efficacy of Dhatu by 
providing proper nourishment. LaghuGuna 
and TikshnaGuna have Sroto-shodhaka 
property, which helps in expelling the morbid 
Doshas 
 
Image No 1: 
 
 
Sutashekhara relives Amlata and 
Tikshanta of Pitta by acting on Amashaya 
and Pakvashaya. Thus it 
regularizesPittotpati. The driver DoshaVata 
also gets pacified by the contents hence 
Chhardi (vomiting) and Bhrama (vertigo) 
subsides in Ardhavabhedaka by use of 
Sutashekhara Rasa. It works as 
Doshpratynika and Vyadhipratynika 
Chikitsa in Ardhavabhedaka.  
The food gets putrificated by 
improper digestion in intestine 
(Vidagdhajeerna) and produces Ama-visha. 
So Rasa-Rakta Dusti and VataVikruti occurs. 
By this process different types of diseases are 
produced. Among them one of the disease is 
Ardhavabhedaka. Sutashekhara is the best 
line of treatment in such type of Ama-
visha. The compound drug is thus having 
Shothahara, Vedanasthapana, 
Deepana,Pachana and 
TridoshaShamakaKarma.  
 
Probable mode of action of Brihat 
Jeevakadya Taila Nasya 
 There are various modalities for the 
alleviation of Shirahshoola. According to 
Acharya Charaka, Nasyakarma is the best 
treatment for the Shiro Roga(10), because, 
nose is the nearest pathway for the 
elimination of Doshas from the head. 
Ardhavabhedaka being one of the Shiroroga 
can be best treated with Nasya in which 
morbid Doshas are situated in the head. In the 
present study Brihat Jeevakadya Taila used 
for Nasya for treatment of Ardhavabhedaka. 
Brihat Jeevakadya Taila is indicated in 
Chakradutta forVata-Pittaja Shirahshoola. 
Jeevaka and Rishabhaka will be representad 
by Vidarikanda due to it’s unavailability.  
 
Importance of Snehana Nasya 
Nasya is the only procedure which 
can directly influence Pranadhisthan and 
Indriya(11): 
 
Image No 2: 
 
 
Dravyas in Taila Paka are Mrudupaka 
(12) 
 
Biphasic nature of this type of process 
(Mrudupaka) i. e.  
1.   Aqueous soluble part of active principle 
will be easily absorbed through mucosa.  
2.   Fat soluble content can be easily 
assimilated through nerve endings.  
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Dominant Rasa Panchaka of Brihat 
Jeevakadya Taila 
Rasa is Madhura,Tikta, 
GunaisGuru, Snigdha, ViryaisSheeta, 
VipakaisMadhura,Doshgnata is Vata-Pitta 
shamaka and Dhatuprabhavais Brihaniya, 
Balya, Jivaniya 
SampraptiVighatana 
In Brihat Jeevakadya Taila most of 
drugs are Brihaniya, Balya, Rasayana, 
Jivaniya, Dahaprasamaka. By virtue of its 
Madhura-Tikta Rasa; Guru-Snigdha 
properties it pacifies Vata-Pitta Dosha. By 
Vata pacifying action may regularize motility 
of the blood vessel wall. By Pitta Shamana 
properties it may be inhibiting release of 
inflammatory mediators like seretonin, 
Prostagladins etc. Action at the level of 
Srotasa: - By improving the microcirculation 
thus allowing improved tissue perfusion and 
nourishment.  
Such drugs probably cause 
Srotovishodhana or cleaning of 
microchannels thus promoting the 
microcirculatory function, which in turn 
produces the desired Rasayana effect and 
improved nutritional status.  
 
Conclusion:  
On the basis of similarities between 
the signs, symptoms, complications, 
prognosis,    chronicity and etymology; 
Ardhavabhedaka and Migraine are similar 
clinical entities. Migraine is a clinical 
diagnosis based on symptoms that are 
subjective and verifiable only by the patient. 
Ardhavabhedaka is clinically Pitta 
dominantly TridoshajaVyadhi. Patients from 
21-40 years of age group, females, 
housewives, married and middle class people 
were more prone to Migraine. Migraine 
sufferers had severe intensity and unilateral 
episodic pain with continuous rhythm. It can 
be inferred that in this study Trial group 
where in Sutashekhara Rasa along with 
Brihat Jeevakadya Taila Nasya is given; was 
showing better results in Ardhavabhedaka 
(Migraine)than Control group (Flunarizine).  
 
Figure no. 1: General Observations (n=30): % 
 
Figure no. 2: Overall Effect of Therapy: 
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TABLE – 01: EFFECT ON HEADACHE (CHIEF COMPLAINT) IN 15 PATIENTS OF 
ARDHAVABHEDAKA IN TRIAL GROUP.  
Headache 
   n Mean 
%  of 
relief 
S. D.  S. E.  T 
P 
 
 
B. T.  A. T.   
Severity 15 03. 87 0. 73 81. 03 0. 35 0. 09 34. 49 <0. 001 
Duration 15 03. 27 0. 73 73. 47 0. 83 0. 21 11. 77 <0. 001 
Frequency 15 03. 87 0. 80 75. 86 0. 59 0. 15 20. 00 <0. 001 
 
 
TABLE – 02: EFFECT ON HEADACHE (CHIEF COMPLAINT) IN 15 PATIENTS OF 
ARDHAVABHEDAKA IN CONTROL GROUP.  
Headache n 
Mean %  of 
relief 
S. D.  S. E.  T P 
B. T.  A. T.  
Severity 15 3. 80 1. 27 66. 66 0. 91 0. 24 10. 72 <0. 001 
Duration 15 2. 73 1. 00 63. 41 1. 22 0. 32 05. 49 <0. 001 
Frequency 15 3. 60 1. 40 61. 11 0. 77 0. 20 11. 00 <0. 001 
 
 
TABLE – 03: EFFECT ON CHIEF COMPLAINTS IN 15 PATIENTS IN TRIAL GROUP.  
Symptoms n 
Mean %  of 
relief 
S. D.  S. E.  T P 
B. T.  A. T.  
Hrillas (Nausea) 13 2. 73 0. 13 95. 12 1. 30 0. 33 7. 76 <0. 001 
Chhardi (Vomiting) 12 1. 93 0. 07 82. 76 1. 19 0. 31 6. 09 <0. 001 
Bhrama (Vertigo) 05 1. 60 00 100 0. 55 0. 24 6. 53 <0. 05 
Purvabhasa (Aura) 11 1. 20 00 100 0. 42 0. 13 9. 00 <0. 001 
 
 
TABLE – 04: EFFECT ON CHIEF COMPLAINTS IN 15 PATIENTS OF 
ARDHAVABHEDAKA IN CONTROL GROUP.  
Symptoms   n 
Mean %  of 
relief 
S. D.  S. E.  T P 
B. T.  A. T.  
Hrillas (Nausea) 14 3. 00 0. 64 78. 57 1. 08 0. 29 8. 15 <0. 001 
Chhardi (Vomiting) 12 1. 83 0. 08 95. 45 0. 87 0. 25 7. 00 <0. 001 
Bhrama (Vertigo) 09 1. 67 0. 44 73. 33 0. 97 0. 32 3. 77 <0. 05 
Purvabhasa (Aura) 09 1. 00 0. 44 55. 55 0. 58 0. 18 3. 16 0. 01 
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TABLE–05: EFFECT ON ASSO. COMPLAINTS IN 15 PATIENTS IN TRIAL GROUP 
Associated 
complaints 
 
n 
Mean 
%  of 
relief 
S. D.  S. E.  T 
P 
Ocular complaints 
B. T.  A. T.   
Blurring of vision 03 1. 50 00 100 0. 71 0. 50 3. 00 >0. 05 
Lacrimation 04 1. 25 00 80. 00 0. 50 0. 25 5. 00 <0. 05 
Eyelid oedema 06 1. 50 0. 17 88. 89 0. 52 0. 21 6. 32 0. 001 
Ocular pain 05 2. 20 0. 20 90. 91 1. 23 0. 55 3. 65 <0. 05 
Supra orbital pain 03 1. 67 0. 33 80. 00 0. 58 0. 33 4. 00 <0. 05 
Heaviness of eyes 04 2. 50 0. 25 90. 00 1. 29 0. 63 3. 57 <0. 05 
Photophobia 11 2. 63 0. 09 96. 55 0. 82 0. 25 10. 29 <0. 001 
Burning sensation 03 2. 00 0. 50 75. 00 0. 71 0. 50 3. 00 >0. 05 
Ear complaints  
Phonophobia 11 2. 64 0. 09 96. 55 0. 82 0. 25 10. 29 <0. 001 
GIT complaints  
Constipation 04 1. 50 00 100 0. 58 0. 29 5. 20 <0. 01 
Hyperchlorhydria 09 1. 56 0. 11 92. 85 0. 53 0. 18 8. 22 <0. 001 
Other complaints  
Sleep disturbance 03 1. 00 1. 00 80. 00 00 00 +inf <0. 001 
Mood swings 07 1. 14 0. 28 75. 00 0. 69 0. 26 3. 28 <0. 01 
Stiffness of neck 06 1. 33 0. 50 62. 50 0. 98 0. 40 2. 08 >0. 05 
Loss of memory 04 1. 00 0. 25 75. 00 0. 50 0. 25 3. 00 <0. 05 
Fear 03 1. 00 00 100 00 00 +inf <0. 001 
 
TABLE –06: EFFECT ON ASSOCIATED COMPLAINTS IN 15 PATIENTS OF 
ARDHAVABHEDAKA IN CONTROL GROUP.  
Associated 
complaints 
 
  n 
Mean %  of 
relief 
S. D.  S. E.  T P 
Ocular complaints B. T.  A. T.  
Blurring of vision 06 1. 83 0. 50 72. 72 0. 52 0. 21 6. 32 0. 001 
Lacrimation 03 1. 67 00 100 0. 58 0. 33 5. 00 <0. 05 
Eyelid oedema 04 1. 75 0. 25 85. 71 0. 58 0. 29 5. 19 <0. 05 
Ocular pain 04 1. 25 0. 25 80. 00 00 00 +inf <0. 001 
Photophobia 08 2. 12 0. 25 88. 23 0. 64 0. 23 8. 27 <0. 001 
Ear complaints  
Phonophobia 09 2. 11 0. 22 89. 47 0. 60 0. 20 9. 43 <0. 001 
Earache 05 1. 50 00 100 0. 58 0. 29 5. 19 <0. 05 
GIT complaints  
Constipation 03 1. 67 0. 67 60. 00 00 00 +inf <0. 001 
Hyperchlorhydria 11 1. 42 0. 92 35. 29 0. 52 0. 15 3. 32 <0. 01 
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Other complaints  
Sleep disturbance 05 1. 14 0. 29 75. 00 0. 69 0. 26 3. 29 <0. 05 
Mood swings 09 1. 11 0. 11 90. 00 00 00 +inf <0. 001 
Stiffness of neck 09 1. 22 0. 22 81. 81 0. 50 0. 17 6. 00 <0. 001 
Loss of memory 04 1. 25 0. 50 60. 00 0. 50 0. 25 3. 00 >0. 05 
Fear 05 1. 40 0. 40 71. 42 0. 70 0. 32 3. 16 <0. 05 
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